Search

everythinglearnresearchcommunity

for

Search:↓

The review recommends hormone replacement therapy for women with premature ovarian insufficiency to manage symptoms and protect health, with specific approaches for different groups.

Oral contraceptives lower testosterone levels in women, especially those with certain genetic traits, and may be linked to increased breast cancer risk.

The editorial concludes that while evidence-based medicine is crucial, doctors should also use their own experience and consider patient preferences in dermatology care.

The NAMS 2014 recommendations guide healthcare providers on treating health issues in midlife women, emphasizing individualized care and informed decision-making.

Taking 5-alpha reductase inhibitors does not increase the risk of breast cancer in men.

Abemaciclib can cause skin, hair, and nail problems, leading some patients to stop using it.

A specific ATR gene mutation is linked to a hereditary oropharyngeal cancer syndrome.

Certain genetic markers linked to reproductive potential were identified by their impact on a protein's ability to bind to genes.

The document concludes that the fast-growing direct-to-consumer genetic testing market lacks sufficient regulation, posing risks to consumers due to questionable test quality and accuracy.

A group has developed therapies that show promise for treating cancer and various other conditions.

Birth control pills slightly increase the risk of breast cancer, especially if used before the first full-term pregnancy.

Preventing cancer involves lifestyle changes, vaccinations, early screening, and understanding cancer's molecular basis.

High TSPEAR levels in colorectal cancer predict worse outcomes.

High TSPEAR levels in colorectal cancer predict worse outcomes.

Different types of fibroblasts play specific roles in wound healing and cancer, which could help improve treatments.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Human hair follicles may provide a noninvasive way to diagnose diseases and have potential in regenerative medicine.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

New targeted cancer drugs can cause skin side effects, and managing them requires patient education and timely care.

Elastic Net DNA methylation clocks are inaccurate for predicting age and health status; a "noise barometer" may better indicate aging and disease.

PCOS may increase the risk of certain cancers.

PCOS is linked to a higher risk of endometrial cancer but not ovarian or breast cancer, and more research is needed on its role in cancer development and treatment effects.

WWOX deficiency in mice causes skin and fat tissue problems due to disrupted cell survival signals.

Using protein degradation to fight cancer drug resistance shows promise but needs more precise targeting and fewer side effects.

Testosterone can help premenopausal and postmenopausal women with low sexual desire, but its long-term safety is unclear and it's not widely approved for this use.

Adding a second method to PROTACs could improve cancer treatment.

After a New York Times article talked about using low-dose oral minoxidil for hair loss, more people started getting this drug prescribed, but this trend didn't last long.

The VEGF +405G allele may increase the risk of PCOS in South Indian women.

Coinheritance of BRCA2 and CYLD genes may lead to new treatment options for certain cancers.